• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者在血压目标范围内停留时间更长可改善心血管结局:一项随机临床试验的二次分析

Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial.

作者信息

Chen KangYu, Wu Zhenqiang, Shi Rui, Wang Qi, Yuan Xiaodan, Wu Guohong, Shi Guoshuai, Li Chao, Chen Tao

机构信息

Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.

Department of Geriatric Medicine, The University of Auckland, Auckland, PO Box 93 503, New Zealand.

出版信息

Diabetes Res Clin Pract. 2023 Apr;198:110600. doi: 10.1016/j.diabres.2023.110600. Epub 2023 Feb 27.

DOI:10.1016/j.diabres.2023.110600
PMID:36858262
Abstract

AIMS

To examine the prognostic value of time in target range (TIR) with adverse outcomes and validate it with common blood pressure (BP) metrics among patients with Type 2 diabetes mellitus.

METHODS

We performed a post hoc analysis of the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial. TIR for each subject was calculated using linear interpolation and an SBP target range of 110 to 130 mmHg. Cox models were used to assess the association of TIR and other BP metrics with the rate of clinical outcomes.

RESULTS

A higher TIR (61.9-100.0 %) was associated with a 46 % reduction in major adverse cardiovascular events (MACE) (hazard ratio [HR]:0.54; 95 % CI: 0.43, 0.67) compared with TIR 0-22.9 %. Results were similar for stroke (0.19; 0.10, 0.36), myocardial infarction (0.67; 0.51, 0.89), heart failure (0.47; 0.33, 0.66), cardiovascular death (0.63; 0.42, 0.93) and all-cause mortality (0.70; 0.54, 0.91). Further analyses suggested a curvilinear association of TIR with MACE, and this association was independent with baseline, final SBP, mean SBP, or visit-to-visit SBP variability.

CONCLUSIONS

Longer TIR is associated with lower cardiovascular risk and may add value as an outcome measure for hypertension control studies among patients with diabetes.

摘要

目的

研究2型糖尿病患者中目标范围内时间(TIR)对不良结局的预后价值,并使用常见血压(BP)指标对其进行验证。

方法

我们对ACCORD(控制糖尿病心血管风险行动)试验进行了事后分析。使用线性插值法计算每个受试者的TIR,收缩压目标范围为110至130mmHg。采用Cox模型评估TIR和其他血压指标与临床结局发生率之间的关联。

结果

与TIR为0-22.9%相比,较高的TIR(61.9-100.0%)与主要不良心血管事件(MACE)减少46%相关(风险比[HR]:0.54;95%置信区间:0.43,0.67)。中风(0.19;0.10,0.36)、心肌梗死(0.67;0.51,0.89)、心力衰竭(0.47;0.33,0.66)、心血管死亡(0.63;0.42,0.93)和全因死亡率(0.70;0.54,0.91)的结果相似。进一步分析表明TIR与MACE呈曲线关联,且这种关联独立于基线、最终收缩压、平均收缩压或每次就诊收缩压变异性。

结论

较长的TIR与较低的心血管风险相关,可能作为糖尿病患者高血压控制研究的结局指标增加价值。

相似文献

1
Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A secondary analysis of a randomized clinical trial.2型糖尿病患者在血压目标范围内停留时间更长可改善心血管结局:一项随机临床试验的二次分析
Diabetes Res Clin Pract. 2023 Apr;198:110600. doi: 10.1016/j.diabres.2023.110600. Epub 2023 Feb 27.
2
Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.在有或没有糖尿病的患者中,收缩压处于目标范围内的临床获益:两项随机临床试验的倾向评分匹配分析。
BMC Med. 2022 Jun 20;20(1):208. doi: 10.1186/s12916-022-02407-z.
3
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.2 型糖尿病患者收缩压变异性与血管事件及过早死亡的相关性及其预后价值: ADVANCE-ON 研究。
Hypertension. 2017 Aug;70(2):461-468. doi: 10.1161/HYPERTENSIONAHA.117.09359. Epub 2017 Jun 5.
4
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.心血管结局和高心血管风险患者的糖尿病与非糖尿病患者的血压控制情况。
Eur Heart J. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149.
5
Target Blood Pressure in Patients with Diabetes: Asian Perspective.糖尿病患者的目标血压:亚洲视角
Yonsei Med J. 2016 Nov;57(6):1307-11. doi: 10.3349/ymj.2016.57.6.1307.
6
Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.伴有和不伴有 2 型糖尿病的患者强化降压治疗:两项随机试验的汇总分析。
Diabetes Care. 2018 Jun;41(6):1142-1148. doi: 10.2337/dc17-1722. Epub 2017 Dec 6.
7
Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.使用计算试验表型图谱和机器学习对高血压患者进行个体化强化收缩压降低治疗:随机临床试验的事后分析。
Lancet Digit Health. 2022 Nov;4(11):e796-e805. doi: 10.1016/S2589-7500(22)00170-4.
8
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.血压变异性对 2 型糖尿病患者大血管和微血管并发症的影响: ADVANCE 试验。
Circulation. 2013 Sep 17;128(12):1325-34. doi: 10.1161/CIRCULATIONAHA.113.002717. Epub 2013 Aug 7.
9
Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trials.强化降压对糖尿病患者的影响:STEP和ACCORD-BP随机试验的汇总分析
Diabetes Obes Metab. 2023 Mar;25(3):796-804. doi: 10.1111/dom.14927. Epub 2022 Dec 9.
10
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.糖尿病心血管风险控制行动(ACCORD)血压试验中的直立性低血压:患病率、发病率及预后意义
Hypertension. 2016 Oct;68(4):888-95. doi: 10.1161/HYPERTENSIONAHA.116.07474. Epub 2016 Aug 8.

引用本文的文献

1
Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis.动态血压监测、欧洲指南目标与心血管结局:一项个体患者数据的荟萃分析。
Eur Heart J. 2025 Aug 8;46(30):2974-2987. doi: 10.1093/eurheartj/ehaf220.
2
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
3
Association Between Systolic Blood Pressure Time in Target Range Indices and Adverse Cardiovascular Outcomes.
收缩压处于目标范围时间指数与不良心血管结局之间的关联
JACC Adv. 2024 Oct 18;3(11):101350. doi: 10.1016/j.jacadv.2024.101350. eCollection 2024 Nov.
4
Blood Pressure Time in Target Range and its Impact on Clinical Outcomes.血压达标时间及其对临床结局的影响。
Curr Cardiol Rep. 2024 Oct;26(10):1145-1151. doi: 10.1007/s11886-024-02111-9. Epub 2024 Aug 14.
5
Blood pressure time at target and its prognostic value for cardiovascular outcomes: a scoping review.血压目标时间及其对心血管结局的预后价值:范围综述。
Hypertens Res. 2024 Sep;47(9):2337-2350. doi: 10.1038/s41440-024-01798-1. Epub 2024 Jul 16.